Over-the-Counter Drugs

Keystone Laboratories has repeatedly failed to correct deficiencies cited by the FDA, including adulteration and misbranding of its over-the-counter drugs, the United States claims in a federal complaint.

MEMPHIS, Tenn. — Keystone Laboratories has repeatedly failed to correct deficiencies cited by the FDA, including adulteration and misbranding of its over-the-counter drugs, the United States claims in a federal complaint.

Categories / Consumers, Health

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Over-the-Counter Drugs

Subscribe to Closing Arguments

Additional Reads